Trial Profile
A phase III trial of NKTR 181 in opioid-experienced patients with chronic low back pain.
Status:
Planning
Phase of Trial:
Phase III
Latest Information Update: 27 Feb 2015
Price :
$35
*
At a glance
- Drugs Oxycodegol (Primary)
- Indications Musculoskeletal pain; Pain
- Focus Therapeutic Use
- Acronyms SUMMIT-12
- Sponsors Nektar Therapeutics
- 27 Feb 2015 New trial record